trial
as of 2026-07-01Stratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation
NCTId NCT06184165
at a glance
— · Not Yet Recruiting
Enrollment 160 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2028-11-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Not Yet Recruiting
Enrollment
160 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2024-03-01
Primary completion
2028-11-01
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Sponsors
University Hospital, Strasbourg, FranceLead Sponsor
Sites
0 total
Facts & assertions
4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2028-11-01
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
lead_sponsor
indication